D-threo-neopterin

DB02385ExperimentalSmall molecule

A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a...

Formula / weight: C₉H₁₁N₅O₄ · 253.2147 g/mol (avg)
Also known as: D-monapterin · D-threo-monapterin · Monapterin · Neopterin D-threo-form

Resolves to

Compound

UNII26C7CRZ5LJCAS10162-32-0ChEBI179056PubChem444632KEGGC05926

Structure

InChIKeyBMQYVXCPAOLZOK-INEUFUBQSA-NSMILESNC1=NC2=NC=C(N=C2C(=O)N1)[C@@H](O)[C@H](O)CO

Which companies are running trials of D-threo-neopterin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account